1. Home
  2. NTCT vs OCS Comparison

NTCT vs OCS Comparison

Compare NTCT & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetScout Systems Inc.

NTCT

NetScout Systems Inc.

HOLD

Current Price

$38.48

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

HOLD

Current Price

$30.37

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTCT
OCS
Founded
1984
2003
Country
United States
Switzerland
Employees
N/A
60
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
NTCT
OCS
Price
$38.48
$30.37
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$31.00
$42.00
AVG Volume (30 Days)
484.0K
464.1K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.06
N/A
Revenue
$891,820,000.00
N/A
Revenue This Year
$6.02
$466.06
Revenue Next Year
$2.55
$479.73
P/E Ratio
$36.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.40
$16.00
52 Week High
$40.92
$34.48

Technical Indicators

Market Signals
Indicator
NTCT
OCS
Relative Strength Index (RSI) 63.75 57.33
Support Level $26.16 $25.95
Resistance Level N/A $30.68
Average True Range (ATR) 1.29 1.49
MACD 0.31 0.19
Stochastic Oscillator 71.58 51.96

Price Performance

Historical Comparison
NTCT
OCS

About NTCT NetScout Systems Inc.

NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Share on Social Networks: